Over 40% of U.S. adults meet the medical classification for obesity, according to the Centers for Disease Control and ...
The FDA has approved the first rapid-acting biosimilar insulin product for glycemic control in people with diabetes. Merilog ...
The FDA approved insulin-aspart-szjj (Merilog) as the first rapid-acting insulin biosimilar product to treat adults and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback